|
| Sample Newsletters | MarketPlace AIS Products & Services |
|
AIS Pharmacy Benefit MarketplaceScroll down to read short descriptions of AIS's Pharmacy Benefit products. Newsletters
Listing Print an order form: If you do not wish to place your order online, click here to download a printable order form (PDF file), then submit your order via fax or mail, as directed on the form.
DRUG BENEFIT NEWS, unique information gathered in AIS's own surveys of HMOs and pharmacy benefit management companies. Timely news and data on the business of pharmaceuticals ... and practical cost management strategies from experts throughout the industry. Includes data on high-cost drug categories, inside info on what HMOs and PBMs are doing, and information that will help you benchmark results and experiences. 24 issues annually ($537 per year) or 2-month intro ($86 for 4 issues); both include print copy and e-mail delivery.
SPECIALTY PHARMACY NEWS, a monthly
newsletter with news and strategies for managing high-cost biotech and
injectable products, designed to help health plans, PBMs, providers
and employers manage costs more aggressively and deliver biotechs and
injectables more effectively. Contains information on benefit design,
provider contracting, reimbursement, network building, claims management,
formulary decisions, and other pharmacy management issues. 12 issues
annually ($495 per year) or 2-month intro ($84 for 2 issues); both include
print copy and e-mail delivery.
10 INDUSTRY-CHANGING TRENDS ON THE PHARMACY BENEFIT HORIZON identifies and provides all the details of 10 major trends that are changing (or should soon alter) the shape of pharmacy benefit management, from discount Rx programs to follow-on biologics to personalized medicine ... and much more. ($124) PDF version also available.
AIS’s QUARTERLY PHARMACY BENEFIT SURVEY RESULTS, a unique resource containing the raw data from AIS’s quarterly survey of PBMs — that tracks growth and consolidation in the industry, and trends in costs, utilization and benefit design. Every four months, a new Excel spreadsheet is available to download, and includes data such as contact information, annual gross revenues, number of clients, number of prescriptions filled per year, and much more. ($150 per quarter)
GENETIC TESTING AND DIAGNOSTIC TOOLS IN THE PHARMACY BENEFIT examines the evolving presence and impact of genetic testing on health plans and the pharmacy benefit industry. It provides insight on coverage implications, pending legislation and government regulation, and some of the science behind the tests. ($84) PDF version available.
GUIDE TO MEDICARE REFORM LAW: OVERVIEW AND HIGHLIGHTS FOR HEALTH PLANS, HOSPITALS AND PROVIDERS, summaries and explanations of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 — in an easy-to-read format with a detailed table of contents for each of the 12 titles of the Act. ($84)
MANAGING CANCER CARE: STRATEGIES TO IMPROVE OUTCOMES AND LOWER COSTS examines recent developments from companies leading the way in the complex oncology management field. This valuable report takes a look at some of the management strategies and pricing methodologies that health plans have been instituting in hopes of reining in costs, as well as the federal government’s role in reimbursement. ($69) PDF version also available.
MEDICARE PART D: A COMPREHENSIVE ANALYSIS OF CMS RULES distills from thousands of pages of CMS regulations and guidance the major rules, guidelines and deadlines you need to comprehend the complex Medicare drug benefit program. It includes nine detailed chapters on sponsors, eligibility and enrollment, formularies, CMS enforcement and much more. ($124)
ONCOLOGY DRUG MANAGEMENT: A WHITE PAPER ON MARKETPLACE CHALLENGES, OPPORTUNITIES AND STRATEGIES, a white paper by pharmacy benefit expert Chris Nee. Filled with data and illustrations that clearly explain the oncology drug management industry’s history and current climate, this white paper includes case studies of various reimbursement scenarios and practical advice on how to design a cost-effective oncology drug program. ($156) PDF version also available.
PART D APPEALS & GRIEVANCES: STRATEGIES FOR MINIMIZING COMPLIANCE RISKS examines key issues surrounding Part D appeals and grievances. This report, based on a January 25, 2007, audioconference, shares expert advice on how to structure an effective appeals and grievances procedure — one that will help you avoid becoming a target of CMS enforcement. ($137) PDF version also available.
PBM CONTRACTING AND TRANSPARENCY ISSUES AND MODELS examines which contracting strategies have been successful, and which have failed or have contributed to confusion among pharmacy benefit clients. It details the decisions that factored into many contract negotiations, both in the public and private sectors, and pays particular attention to the role of transparency in these negotiations. ($84) PDF version also available.
PRESCRIPTION DRUG REBATES AND EVOLVING REIMBURSEMENT METHODOLOGIES is a primer on the basics of drug rebates — how they have evolved over the years and continue to change. It examines how the health care industry has reacted to new reimbursement methodologies, and details strategies that have been successful, as well as ones that have increased confusion or conflict. ($84) PDF version available.
SPECIALTY PHARMACY: STAKEHOLDERS, STRATEGIES AND MARKETS, a comprehensive picture of the specialty pharmacy marketplace. Includes hard data and statistics on the vendors serving this health care sector, the products involved, and the strategies employed by payers for managing and delivering these products to members. ($341) CD version also available.
Meetings are listed
below in reverse chronological order,
INNOVATIVE ONCOLOGY PARTNERSHIPS: HOW TO IMPROVE OUTCOMES AND EFFICIENCIES, a recording of a 90-minute audioconference held on October 29, 2008. A team of experts — Lynn Nishida, director of clinical pharmacy services for RegenceRx, Richard McGee, M.D., a medical oncologist and co-founder and president of Puget Sound Cancer Centers, Nicholas Opalich, the managing principal of Strategica Health Partners, L.L.C., and David Chess, M.D., founder and CEO of Enhanced Care Initiatives Inc.— outline effective strategies that payers and providers can use collaboratively to improve clinical outcomes and increase efficiencies. ($329)
VACCINE COVERAGE AND BILLING STRATEGIES UNDER PART D, a recording of a 90-minute audioconference held on September 25, 2008. Andrea Serrate, CPA, vice president of specialty and payer services for Poc Network Technologies, Inc., provides valuable intelligence about CMS’s new vaccine coverage and administration billing requirements and options. Learn how to cover and bill for vaccines correctly to avoid CMS sanctions and enforcement action. ($329)
FINDING ‘VALUE’ IN VALUE-BASED Rx BENEFITS: ROI STRATEGIES FOR HEALTH PLANS AND EMPLOYERS, a recording of a 90-minute audioconference held on September 18, 2008. Two leading experts on value-based programs — Jack Mahoney, M.D., corporate medical director and global health care management director at Pitney Bowes Inc., and Brian Sweet, chief pharmacy officer at WellPoint, Inc. — offer their strategic insights on how health plans and self-insured employers can see a significant return on investment out of their value-based insurance design (VBID) programs. ($329)
NEXT-GENERATION SPECIALTY PHARMACY MANAGEMENT STRATEGIES FOR HEALTH PLANS, a recording of a 90-minute audioconference held on July 9, 2008. Find out what new strategies insurers are using — and should use — to manage high-cost specialty drugs, from Debbie Stern, R.Ph., vice president of Rxperts, and Edmund Pezalla, M.D., national medical director at Aetna Pharmacy Management. ($329)
HOW TO LOWER RX COSTS IN PBM CONTRACTS: STRATEGIES FOR HEALTH PLANS AND EMPLOYERS, a CD of a 90-minute audioconference held on June 12, 2008. Get expert guidance about the RFP process, PBM contracts, and the crucial strategies Rx payers should employ to achieve the lowest feasible drug spend — and not waste millions of dollars. Speakers are: Linda Cahn, president of Pharmacy Benefit Consultants, and Dan Coady, director of pharmacy benefit administration (PBA) strategies at HealthTrans LLC. ($329)
PART D ENFORCEMENT PITFALLS: HOW TO IDENTIFY AND ELIMINATE FRAUD AND ABUSE IN YOUR DOWNSTREAM ENTITIES, a CD of a 90-minute audioconference held on March 13, 2008. Find out urgent new compliance challenges Part D plans face in light of CMS’ recently finalized regs that increase sponsor responsibilities for downstream entities … and learn steps you can take to identify and eliminate fraud and abuse at the various contact points for beneficiaries. Hear from Susan Hayes, principal and founder of Pharmacy Outcome Specialists and Steve Arbaugh, principal with ATTAC Consulting Group, LLC. ($329)
ORAL ONCOLOGY DRUGS: HEALTH PLAN STRATEGIES FOR AN EVOLVING MARKET, a CD of a 90-minute audioconference held on February 28, 2008. Find out what strategies plans are (or should be) using to manage oral oncology drugs, and what trends insurers should prepare for — from Lee N. Newcomer, M.D., senior vice president of oncology for UnitedHealthcare, Randy Falkenrath, senior vice president of specialty pharmacy and business development for UnitedHealth Pharmaceutical Solutions (UHPS), and Thomas McNulty, Pharm.D., chief clinical officer for Ancillary Care Management, Inc. (ACM). ($329)
“DRUG MIX” STRATEGIES FOR HEALTH PLANS AND PBMs: WAYS TO LOWER Rx COSTS AND WIN BUSINESS, a CD of a 90-minute audioconference held on February 13, 2008. Three leading pharmacy experts — Jake Cedergreen of Express Scripts, Helen Sherman of The Regence Group's RegenceRx and Tim Watson of Pharmaceutical Strategies Group — provide strategic insights on how health plans and PBMs can develop an effective drug mix, and thereby differentiate themselves in the marketplace. ($329)
EFFECTIVE HEALTH PLAN STRATEGIES FOR MANAGING EPOETIN PRODUCTS, a CD of a 90-minute audioconference held on September 27, 2007. Find out how health plans are managing drugs like Epogen and Procrit to assure best health outcomes for patients, and best financial outcomes for their own bottom lines. Speakers are: Helen Sherman, R.Ph., Pharm.D., senior director of pharmacy services and chief pharmacy officer at The Regence Group's RegenceRx, and Michael Joslin, chief operating officer of CareCore Oncology and executive vice president of CareCore National, LLC. ($322)
SPECIALTY INFUSION MANAGEMENT: EFFECTIVE STRATEGIES FOR HEALTH PLANS, a CD of a 90-minute audioconference held on July 18, 2007. Find out how health plans are managing infusibles, and how new drugs in the pipeline and proposed federal legislation could severely impact the bottom lines of commercial and Medicare health plans. Speakers are: David Willcutts, chief executive officer at Ancillary Care Management, Inc., and Bruce Rodman, M.B.A., vice president, health information policy for the National Home Infusion Association. ($322)
EFFECTIVE ONCOLOGY MANAGEMENT STRATEGIES FOR HEALTH PLANS, a CD of a 90-minute audioconference held on March 20, 2007. Learn how to design flexible programs that manage out-of-control oncology drug costs without compromising patient outcomes — from Robin U. Smith, president of Biologics, Inc., and Al Heaton, director of pharmacy at Blue Cross Blue Shield of Minnesota. ($322)
MANAGING RHEUMATOID ARTHRITIS: STRATEGIES FOR HEALTH PLANS, a CD of a 90-minute audioconference held on December 7, 2006. Find out promising ways to improve outcomes and reduce costs, which should trend even higher with expensive new RA drugs in the pipeline. Speakers are Helen Sherman, R.Ph., Pharm.D., director of pharmacy services at The Regence Group's RegenceRx, and Debbie Stern, R.Ph., vice president of managed care consulting firm Rxperts. ($292)
PART
D
VS.
PART
B:
HOW
TO
SOLVE
COMPLEX
COVERAGE
&
BILLING
PROBLEMS,
a
CD
of
a
two-hour
audioconference
held
on
April
27,
2006.
Gorman
Health
Group's
Babette
S.
Edgar,
Wendy
Weingart
and
Sharon
M.
Durfee
discuss
how
to
determine
the
correct
coverage
for
Part
B-only
drugs,
Part
D-only
drugs,
and
D
vs.
B
“crossover”
drugs,
so
you
can
head
off
compliance
problems
and
save
your
organization
from
lost
reimbursement.
($292)
Place an order or get more information at 800-521-4323 |
Copyright ©
2009 by Atlantic Information Services, Inc. All rights reserved.
1100 17th Street, NW, Suite 300, Washington, DC 20036
Phone 202-775-9008 or 800-521-4323; E-mail customerserv@aispub.com
1100 17th Street, NW, Suite 300, Washington, DC 20036
Phone 202-775-9008 or 800-521-4323; E-mail customerserv@aispub.com